Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 1;105(7):e68-e69.
doi: 10.1097/TP.0000000000003737.

Casirivimab-imdevimab for Treatment of COVID-19 in Solid Organ Transplant Recipients: An Early Experience

Abhay Dhand  1 , Stephen A Lobo  1 , Kevin Wolfe  2 , Nicholas Feola  3 , Leslie Lee  3 , Rajat Nog  1 , Donald Chen  1 , Daniel Glicklich  1 , Thomas Diflo  2 , Christopher Nabors  1
Affiliations

Casirivimab-imdevimab for Treatment of COVID-19 in Solid Organ Transplant Recipients: An Early Experience

Abhay Dhand et al. Transplantation. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

A.D. and SAL received institutional research grant from Regeneron outside this work. The other authors declare no conflicts of interest.

Comment in

References

    1. Food and Drug Administration. Casirivimab and Imdevimab EUA Letter of Authorization. Available at https://www.fda.gov/media/143891/download Accessed February 10, 2021
    1. Pereira MR, Mohan S, Cohen DJ, et al. COVID-19 in solid organ transplant recipients: initial report from the US epicenter. Am J Transplant. 2020; 20:1800–1808
    1. Weinreich DM, Sivapalasingam S, Norton T, et al.; Trial Investigators. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med. 2021; 384:238–251

Publication types

Substances

LinkOut - more resources